GlucoTrack Inc GCTK
NASDAQ · United States · Health Technology
$1.21-0.20 (-14.18%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
RUTHERFORD, N.J. & LA JOLLA, Calif., October 01, 2026--Lōkahi expands its UGA collaboration internationally with Universität Paderborn, increasing ai² platform capacity and strategic revenue opportunities.
RUTHERFORD, N.J. & LA JOLLA, Calif., September 30, 2026--Lōkahi Therapeutics™ announces Qare™, a new comparative health platform for GLP-1 users, available beginning October 14, 2026.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
RUTHERFORD, N.J. & LA JOLLA, Calif., September 25, 2026--Lōkahi Therapeutics™ partners with Pepperdine E2B™ to expand ai² Pipeline™, engaging MBA students in evaluating biopharmaceutical assets.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.